
Recipharm announced a significant investment in its Oral Solid Development and Pilot Scale Centre in Zwickau, Germany. The investment includes three new GMP Pilot Scale suites for blending, tableting and hard capsule filling, which will complement the existing GMP pilot scale capabilities in dry granulation and wet granulation and related tools for material characterization and material science.
The investment includes:
- A pilot scale hard capsule filler with dual filling and mini tablet dosing capabilities
- A Style One EVO Compression and Compaction Simulator, which complements the existing pilot scale dry granulation and tableting capabilities
- A pilot scale tablet press.
The new pilot scale center for dry technologies will be GMP-ready by Q1 2025.
This goes hand in hand with ReciPredict – an innovative combination and systematic application of material sciences, statistical tools and simulation. ReciPredict promises to deliver unparalleled efficiency and reliability to the pharmaceutical industry, by streamlining the product development cycle, from initial formulation through to manufacturing.
Dr. Uwe Hanenberg, PhD, Head of Product Implementation, commented: "With these advancements, we can now offer late-stage product development, clinical supply and commercial manufacturing from a single site. This integration makes it more efficient and cost-effective for our customers, providing them with access to top experts, while ensuring efficiencies in material consumption, including APIs. With our investment in ReciPredict as well as the GMP pilot scale for dry granulation and now the pilot scale for dry technologies, we have the tools and equipment at hand to support our custom with a faster clinic-to-market timeline for new drugs and de-risking manufacturing, ensuring greater certainty in meeting customer needs."
With its new capabilities Recipharm in Zwickau is the ideal partner for API and excipient characterization, product and process development, clinical Ph II and Ph III supply, small scale batch manufacturing, scale up and tech transfers, product optimization and life cycle management.